Detalhe da pesquisa
1.
Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment.
JACC Basic Transl Sci
; 6(12): 984-999, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024504